서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 242

Issue DateTitle / Author(s) / CitationFileAltmetrics
1994
Multiple myeloma presenting as a testicular mass.

Kang, Min Jong; Kim, Tae You; Bang, Yung-Jue; Heo, Dae Seog; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyoung; Kim, Chul Woo

The Korean Journal of Internal Medicine, Vol.9 No.1, pp.39-42

DOI
1997-03
Mutation of ras oncogene in gastric adenocarcinoma: Association with histological phenotype

Kim, TY; Bang, YJ; Kim, WS; Kang, SH; Lee, KU; Choe, KJ; Kim, NK

Anticancer Research, Vol.17 No.2B, pp.1335-1339

2001-01
CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface
DOI
2001-04
A phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies
DOI
2002-03
Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression

Jong, Hyun-Soon; Lee, Ho Soon; Kim, Tae You; Im, Young-Hyuck; Park, Jae-Won; Kim, Noe Kyeong; Bang, Yung-Jue

Biochemical and Biophysical Research Communications, Vol.292 No.2, pp.383-389

DOI
2002-05
Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: A case-control study
DOI
2002-05
Ramosetron for the prevention of cisplatin-induced acute emesis: A prospective randomized comparison with granisetron

Kang, YK; Park, YH; Ryoo, BY; Bang, YJ; Cho, KS; Shin, DB; Kim, HC; Lee, KH; Park, YS; Lee, KS; Heo, DS; Kim, SY; Cho, EK; Lim, HY; Kim, WK; Lee, JA; Kim, TY; Lee, JC; Yoon, HJ; Kim, NK

Journal of International Medical Research, Vol.30 No.3, pp.220-229

DOI
2002-06
A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer
DOI
2002-08
p130 mediates TGF-β-induced cell-cycle arrest in Rb mutant HT-3 cells
DOI
2002-11
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer

Chang, HM; Jung, KH; Kim, TY; Kim, WS; Yang, HK; Lee, KU; Choe, KJ; Heo, DS; Bang, YJ; Kim, NK

Annals of Oncology, Vol.13 No.11, pp.1779-1785

DOI
2003-01
Gastric Epithelial Reactive Oxygen Species Prevent Normoxic Degradation of Hypoxia-inducible Factor-1α in Gastric Cancer Cells
2003-01
Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer
DOI
2003-01
Induction chemotherapy followed by radiotherapy in the treatment of anal cancer
DOI
2003-03
Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer

Kim, DY; Kim, JH; Lee, SH; Kim, TY; Heo, DS; Bang, YJ; Kim, NK

Annals of Oncology, Vol.14 No.3, pp.383-387

DOI
2003-06
Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells
DOI
2003-10
A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells
DOI
2003-11
Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy - Result of chemotherapy in NK/T-cell lymphoma
DOI
2003-12
Synthesis and Biological Evaluation of 3-(4-Substituted-phenyl)-N-hydroxy-2-propenamides, a New Class of Histone Deacetylase Inhibitors
DOI
2003-12
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients - Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage
DOI
2003-12
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone
DOI
2004-02
Transforming growth factor-β1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells
DOI
2004-03
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen
DOI
2004-04
Aberrant methylation of integrin α4 gene in human gastric cancer cells
DOI
2004-05
Smad2 mediates Erk1/2 activation by TGF-β1 in suspended, but not in adherent, gastric carcinoma cells
DOI
2004-06
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
DOI
2004-07
DNA hypermethylation in gastric cancer

Kim, T. Y.; Jong, H. S.; Jung, Y.; Kim, T. Y.; Kang, G. H.; Bang, Y. J.

Alimentary Pharmacology and Therapeutics, Vol.20 No.1, pp.131-142

DOI
2004-07
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy
DOI
2004-08
Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation
DOI
2004-09
AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity
DOI
2004-11
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma
DOI
2004-11
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2004-12
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma
DOI
2005-01
Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
DOI
2005-01
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer
DOI
2005-03
Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis
DOI
2005-04
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
DOI
2005-06
Cytotoxic effects of pemetrexed in gastric cancer cells
DOI
2005-07
Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer
DOI
2005-07
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer
DOI
2005-08
The signaling network of transforming growth factor β1, protein kinase C delta, and integrin underlies the spreading and invasiveness of gastric carcinoma cells
view fileDOI
2005-08
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor
DOI
2005-09
Management of gastric lymphoma with chemotherapy alone

Oh, D. Y.; Choi, I. S.; Kim, J. H.; Rhu, M. H.; Kim, T. Y.; Heo, Dae Seog; Bang, Y. J.; Kim, N. K.

Leukemia and Lymphoma, Vol.46 No.9, pp.1329-1335

DOI
2005-10
The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3
DOI
2005-10
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer
DOI
2005-12
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type
DOI
2005-12
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
DOI
2006-01
Histone Deacetylase Inhibitors for Cancer Therapy

Kim, Tae-You; Bang, Yung-Jue; Robertson, Keith D.

Epigenetics, Vol.1 No.1, pp.14-23

DOI
2006-02
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
DOI
2006-03
Antibiotic use during the last days of life in cancer patients

Oh, D. Y.; Kim, J. H.; Kim, D. W.; Im, S. A.; Kim, T. Y.; Heo, D. S.; Bang, Y. J.; Kim, N. K.

European Journal of Cancer Care, Vol.15 No.1, pp.74-79

DOI
2006-04
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation
DOI
2006-06
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
DOI
2006-07
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
DOI
2006-07
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy
DOI
2006-08
Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome
view fileDOI
2006-09
Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells
2006-11
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients
DOI
2006-12
Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells

Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue

Molecular Cancer Therapeutics, Vol.5 No.12, pp.3085-3095

DOI
2007-03
DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma

Kim, Tai Young; Lee, Jung Weon; Kim, Hwang-Phill; Jong, Hyun-Soon; Kim, Tae-You; Jung, Mira; Bang, Yung-Jue

Biochemical and Biophysical Research Communications, Vol.355 No.1, pp.72-77

DOI
2007-04
Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression

Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Kim, Hwang-Phill; Park, Jung-Hyun; Jung, Yeonjoo; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You

Biochemical and Biophysical Research Communications, Vol.355 No.2, pp.318-323

DOI
2007-04
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
view fileDOI
1 2 3 4 5